Medscape |
Withhold Gliptins From Diabetics With Heart Failure?
Medscape BARCELONA, Spain — New data from EXAMINE, the cardiovascular-safety trial with the type 2 diabetes drug alogliptin (Nesina, Takeda Pharmaceuticals), has shown no significantly increased risk for heart failure (HF) with use of this dipeptidyl peptidase … |
Drug companies seek to deliver patents message to Indian prime minister – Politico
Politico |
Drug companies seek to deliver patents message to Indian prime minister
Politico Drug manufacturers say India’s most egregious act came in March 2012, when its controller general of patents, designs and trademarks granted a compulsory license for local generics company Natco to sell a copy of Bayer’s Nexavar, which treats liver and … |
Research and Markets: Global Monoclonal Antibodies Pipeline Capsule – 2013 … – Fort Mills Times
Research and Markets: Global Monoclonal Antibodies Pipeline Capsule – 2013 …
Fort Mills Times The latest report ‘Global Monoclonal Antibodies Pipeline Capsule – 2013′ provides up-to-date information on key Research and Development activities (R&D) in the global monoclonal antibodies market. It covers active monoclonal antibodies pipeline … |
Boxed warning for HBV risk added to Rituxan, Arzerra – Clinical Advisor
Medscape |
Boxed warning for HBV risk added to Rituxan, Arzerra
Clinical Advisor The FDA has announced that the anti-CD20-directed monoclonal antibodies rituximab (Rituxan) and ofatumumab (Arzerra) will carry a boxed warning for immunosupression-related reactivation of hepatitis B virus (HBV) in a drug safety communication. Boxed Warning on HBV Reactivation for Blood Cancer DrugsMedscape FDA updates ‘box warning’ for Arzerra and Rituxan to include Hepatitis B …The Global Dispatch Boxed warning for potential HBV reactivation added to Arzerra, Rituxan labelingHealio Pharmaceutical Processing all 5 news articles » |
Project Recovery turns unused blood products from Canadian blood donations … – PR Newswire India (press release)
Project Recovery turns unused blood products from Canadian blood donations …PR Newswire India (press release)Canadian Blood Services also oversees the OneMatch Stem Cell and Marrow Network, and provides national leadership for organ and tissue donati…
Chinese man has new nose grown on his forehead – Metro
Metro |
Chinese man has new nose grown on his forehead
Metro These astonishing pictures show Xiaolian, 22, at a hospital in Fuzhou, Fujian province, as doctors check on his progress ahead of transplant surgery. The patient underwent the unusual procedure after he neglected nasal trauma treatment following a … New nose grown on man’s foreheadCANOE New nose grown by surgeons to replace original oneBBC News Amazing photos show man’s new nose grown on his foreheadAtlanta Journal Constitution International Business Times –The Frisky all 130 news articles » |
Boxed warning for potential HBV reactivation added to Arzerra, Rituxan labeling – Healio
Boxed warning for potential HBV reactivation added to Arzerra, Rituxan labeling
Healio Rituxan (rituximab, Genentech) is a therapy for CLL, non-Hodgkin’s lymphoma and conditions that include microscopic polyangiitis, granulomatosis with polyangiitis and rheumatoid arthritis. These drugs, along with other CD20-directed cytolytic … |
Boxed Warning on HBV Reactivation for Blood Cancer Drugs – Medscape
MedscapeBoxed Warning on HBV Reactivation for Blood Cancer DrugsMedscapeA boxed warning about the risk for reactivation of hepatitis B virus (HBV) infection in patients who once had the virus has been added to the product labeling for 2 drugs used in t…
Work force in 30-44 age group high on heart disease risk: Study – Economic Times
Economic Times |
Work force in 30-44 age group high on heart disease risk: Study
Economic Times This meant that Young India’s heart is ageing much faster. The study on risk factors causing heart disease, revealed that 73 per cent males in the age group of 30-34 years and 76 per cent in 35-39 age group are at cardiovascular disease (CVD) risk and … |
Shark antibodies may aid breast cancer fight – Telegraph.co.uk
Telegraph.co.ukShark antibodies may aid breast cancer fightTelegraph.co.ukIt is thought that the unique IgNAR antibodies could be used to prevent the growth of cancer cells and research into them could lead to the development of new drugs to fight the …